SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Najla A. Lakkis, Dina M. Mahmassani, Ghassan N. Hamadeh, Diabetes quality of care at a university community in Beirut, Journal of Evaluation in Clinical Practice, 2015, 21, 5
  2. 2
    John P.H. Wilding, Lawrence Blonde, Lawrence A. Leiter, Sonia Cerdas, Cindy Tong, Jacqueline Yee, Gary Meininger, Efficacy and safety of canagliflozin by baseline HbA1c and known duration of type 2 diabetes mellitus, Journal of Diabetes and its Complications, 2015, 29, 3, 438

    CrossRef

  3. 3
    Manuel Pérez-Maraver, Gracia Romero Meliá, Jordi Caballero Corchuelo, Eficacia y seguridad de una estrategia basal plus en pacientes con diabetes mellitus tipo 2 en la práctica clínica especializada. El estudio Basal Plus en España, Avances en Diabetología, 2015, 31, 2, 64

    CrossRef

  4. 4
    Sang Soo Kim, In Joo Kim, Yong Ki Kim, Kun Ho Yoon, Ho Young Son, Sung Woo Park, Yeon Ah Sung, Hong Sun Baek, Insulin Initiation in Insulin-Naïve Korean Type 2 Diabetic Patients Inadequately Controlled on Oral Antidiabetic Drugs in Real-World Practice: The Modality of Insulin Treatment Evaluation Study, Diabetes & Metabolism Journal, 2015, 39, 6, 481

    CrossRef

  5. 5
    S. Halimi, B. Charbonnel, P. Monguillon, S. Dejager, Le diabète de type 2 au stade de l’insuline : Quelle place pour les inhibiteurs de la DPP-4 ?, Médecine des Maladies Métaboliques, 2015, 9, 1, 53

    CrossRef

  6. 6
    Christof Lipowsky, Lisa Sze, Ina Krull, Michael Brändle, Liraglutide as Add-On Therapy to Insulin in Type 2 Diabetes Mellitus: A Retrospective, Observational Study From a Daily Clinical Practice Setting in Switzerland, Diabetes Therapy, 2015, 6, 1, 41

    CrossRef

  7. 7
    Kyong Hye Joung, Jae-Wook Jeong, Bon Jeong Ku, The Association between Type 2 Diabetes Mellitus and Women Cancer: The Epidemiological Evidences and Putative Mechanisms, BioMed Research International, 2015, 2015, 1

    CrossRef

  8. 8
    L. J. Schmidt, W. Habacher, T. Augustin, E. Krahulec, T. Semlitsch, A systematic review and meta-analysis of the efficacy of lixisenatide in the treatment of patients with type 2 diabetes, Diabetes, Obesity and Metabolism, 2014, 16, 9
  9. 9
    Stephen Brunton, Timothy S. Reid, Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, for the Management of Type 2 Diabetes, Hospital Practice, 2014, 42, 3, 96

    CrossRef

  10. 10
    David Polidori, Andrea Mari, Ele Ferrannini, Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes, Diabetologia, 2014, 57, 5, 891

    CrossRef

  11. 11
    Sang Soo Kim, In Joo Kim, Yong Ki Kim, Kun Ho Yoon, Ho Young Son, Sung Woo Park, Yeon Ah Sung, Hong Sun Baek, Kyoung Soo Ha, Duration of diabetes and effectiveness of insulin in the management of insulin-naïve Korean patients uncontrolled on oral antidiabetic drugs: a sub-analysis of the MOdaliTy of Insulin treatment eValuation (MOTIV) registry results, Acta Diabetologica, 2014, 51, 4, 655

    CrossRef

  12. 12
    Kathrin Herrmann, Kevin Shan, Steven Brunell, Steve Chen, Effects of Pramlintide in Patients with Type 2 Diabetes Mellitus: An Analysis Using Daily Insulin Dose Tertiles, Endocrine Practice, 2014, 20, 10, 1070

    CrossRef

  13. 13
    Jin Ha Lee, Tae Il Kim, Type II Diabetes, Metformin Use, and Colorectal Neoplasia: Mechanisms of Action and Implications for Future Research, Current Colorectal Cancer Reports, 2014, 10, 1, 105

    CrossRef

  14. 14
    Bernard Charbonnel, Anja Schweizer, Sylvie Dejager, Combination Therapy With DPP-4 Inhibitors and Insulin in Patients With Type 2 Diabetes Mellitus: What Is the Evidence?, Hospital Practice, 2013, 41, 2, 93

    CrossRef

  15. 15
    H. W. Rodbard, B. Cariou, B. Zinman, Y. Handelsman, A. Philis-Tsimikas, T. V. Skjøth, A. Rana, C. Mathieu, Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial, Diabetic Medicine, 2013, 30, 11
  16. 16
    Samy L. Habib, Maciej Rojna, Diabetes and Risk of Cancer, ISRN Oncology, 2013, 2013, 1

    CrossRef

  17. 17
    Manel Mata-Cases, Estudio observacional de eficacia y seguridad del cambio de insulina NPH a glargina en atención primaria. Estudio LAURA, Avances en Diabetología, 2013, 29, 5, 137

    CrossRef

  18. 18
    N. A. Lakkis, G. J. Maalouf, D. M. Mahmassani, G. N. Hamadeh, Insulin therapy attitudes and beliefs of physicians in Middle Eastern Arab countries, Family Practice, 2013, 30, 5, 560

    CrossRef

  19. 19
    Hyoseok Kang, Current therapeutic agents and anesthetic considerations for diabetes mellitus, Korean Journal of Anesthesiology, 2012, 63, 3, 195

    CrossRef

  20. 20
    Marisa Desimone, Gary Blank, Mohamed Virji, Amy Donihi, Monica DiNardo, Deborah Simak, Raquel Buranosky, Mary Korytkowski, Effect of an Educational Inpatient Diabetes Management program on Medical Resident Knowledge and Measures of Glycemic Control: A Randomized Controlled Trial, Endocrine Practice, 2012, 18, 2, 238

    CrossRef

  21. 21
    S. E. Inzucchi, R. M. Bergenstal, J. B. Buse, M. Diamant, E. Ferrannini, M. Nauck, A. L. Peters, A. Tsapas, R. Wender, D. R. Matthews, Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), Diabetologia, 2012, 55, 6, 1577

    CrossRef

  22. 22
    S. E. Inzucchi, R. M. Bergenstal, J. B. Buse, M. Diamant, E. Ferrannini, M. Nauck, A. L. Peters, A. Tsapas, R. Wender, D. R. Matthews, Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), Diabetes Care, 2012, 35, 6, 1364

    CrossRef

  23. 23
    Prise en charge de l’hyperglycémie chez le patient diabétique de type 2 : une stratégie centrée sur le patient, Médecine des Maladies Métaboliques, 2012, 6, III

    CrossRef

  24. 24
    E. Giovannucci, D. M. Harlan, M. C. Archer, R. M. Bergenstal, S. M. Gapstur, L. A. Habel, M. Pollak, J. G. Regensteiner, D. Yee, Diabetes and Cancer: A consensus report, Diabetes Care, 2010, 33, 7, 1674

    CrossRef